-6.9%
CHYM vs AVAV
-25.0%
+18.1%
-55.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.9% | -5.4% | +12.3% | +8.0% |
| 7D | +3.4% | -3.2% | +6.6% | +3.9% |
| 30D | +12.0% | -25.6% | +37.6% | +18.8% |
| 3M | +102.4% | -20.2% | +122.6% | +109.4% |
| 6M | +52.7% | -38.1% | +90.7% | +65.4% |
| YTD | +37.3% | -41.8% | +79.1% | +45.1% |
| 1Y | +42.2% | -39.0% | +81.2% | +44.8% |
| All | -6.9% | -25.0% | +18.1% | -11.9% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling